uniQure N.V.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
19.46
0.16
(0.829%)
Volume:
431,924
52 week range:
12.52 - 28.26
Market Cap:
914.279M
Company Description:
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.